Vaginal ring treats vasomotor and local symptoms

Healthcare professionals will soon be able to offer women the first vaginal estrogen product that treats both the vasomotor and vaginal symptoms of menopause. The FDA recently approved estradiol (Femring, Galen Holdings) vaginal ring for the treatment of moderate to severe vasomotor symptoms associated with menopause and treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause. Femring will be available in pharmacies in June.

© 2023 MJH Life Sciences

All rights reserved.